The clinical features of PRKN-related PD were notable for the following points: early onset, mostly before 45 years old, responsive to levodopa, progressing slowly, commonly exhibiting dystonia, nearly half exhibiting hyperreflexia, no observed olfactory dysfunction, and limited suffering from dementia (9, 23–28). This evidence concerns the gene PRKN and dementia.